BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 751 | Download: 1730
 |
Received |
|
2021-01-13 21:55 |
|
Peer-Review Started |
|
2021-01-13 21:57 |
|
First Decision by Editorial Office Director |
|
2021-04-20 22:50 |
|
Return for Revision |
|
2021-04-20 22:50 |
|
Revised |
|
2021-04-23 21:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-05-19 06:49 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-05-19 12:04 |
|
Articles in Press |
|
2021-05-19 12:04 |
|
Edit the Manuscript by Language Editor |
|
2021-05-27 18:49 |
|
Typeset the Manuscript |
|
2021-06-03 06:14 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Effect of COVID-19 on management of diabetes type 1: Pushing the boundaries of telemedical healthcare
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ines Bilic Curcic, Maja Cigrovski Berkovic, Tomislav Kizivat, Silvija Canecki Varzic, Robert Smolic and Martina Smolic |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ines Bilić-Ćurčić |
ZUP2018-90 |
|
| Corresponding Author |
Martina Smolic, MD, PhD, Associate Professor, Department for Pharmacology, Faculty of Medicine Osijek, J Huttlera 4, Osijek 31000, Croatia. martina.smolic@mefos.hr |
| Key Words |
Diabetes management; Telemedicine; COVID-19; Diabetes type 1 |
| Core Tip |
Mortality and morbidity rates are increased during coronavirus disease 2019 pandemics partially due to disruption in health care delivery. The implementation of telemedicine imposes itself as a logical solution given technical devices and apps already available in management of type 1 diabetes (DMT1). Presently available data are scarce, but encouraging regarding glycemic control in long standing DMT1, new onset DMT1 and minimizing acute complications. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Bilic Curcic I, Cigrovski Berkovic M, Kizivat T, Canecki Varzic S, Smolic R, Smolic M. Effect of COVID-19 on management of diabetes type 1: Pushing the boundaries of telemedical healthcare. World J Diabetes 2021; 12(6): 780-785 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/780.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.780 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
